Table 2.
“Re-staging” after 11C-choline PET/CT.
| Patient | Re-staging (type) | N pre PETa | N pos PETb | M pre PETc | M pos PETd |
|---|---|---|---|---|---|
| 1 | No | − | − | − | − |
| 2 | Yes (decrease) | − | − | + | − |
| 3 | No | − | − | − | − |
| 4 | Yes (increase) | − | + | − | − |
| 5 | No | − | − | − | − |
| 6 | Yes (increase) | − | + | − | − |
| 7 | Yes (increase) | − | + | − | − |
| 8 | No | − | − | − | − |
| 9 | No | − | − | − | |
| 10 | Yes (increase) | − | − | − | + |
| 11 | No | − | − | − | − |
| 12 | Yes (increase) | − | + | − | − |
| 13 | No | − | − | − | − |
| 14 | No | − | − | − | − |
| 15 | No | − | − | − | − |
| 16 | No | − | − | − | − |
a
N pre PET: nodal status prior 11C-choline PET/CT.
b
N pos PET: nodal status after 11C-choline PET/CT.
c
M pre PET: systemic metastatic status prior 11C-choline PET/CT.
d
M pos PET: systemic metastatic status after 11C-choline PET/CT.